SBI Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Sell
1,850
-20
-1% -$2.17K 0.01% 572
2026
Q1
$173K Sell
1,870
-79
-4% -$7.93K ﹤0.01% 675
2025
Q4
$199K Sell
1,949
-135
-6% -$12.1K 0.01% 632
2025
Q3
$130K Buy
2,084
+718
+53% +$39.1K ﹤0.01% 765
2025
Q2
$71.1K Buy
1,366
+681
+99% +$30.4K ﹤0.01% 925
2025
Q1
$29.2K Sell
685
-730
-52% -$31.5K ﹤0.01% 1186
2024
Q4
$43.2K Buy
+1,415
New +$39.8K ﹤0.01% 1031

Other funds holding GH

SBI Securities's GH Position: Q2 2026 in Review

SBI Securities reduced its Guardant Health (GH) stake by 1.1% in Q2 2026, selling an estimated $2.17K and leaving 1,850 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #572.

SBI Securities first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • SBI Securities held 1,850 shares of Guardant Health worth $278K as of Q2 2026.
  • SBI Securities sold 20 Guardant Health shares in Q2 2026, an estimated $2.17K.
  • Guardant Health made up 0.01% of SBI Securities's portfolio in Q2 2026, its #572 holding.
  • SBI Securities first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.